- 01A changed urine ratio is not a changed symptom
In the largest trial, DIM shifted which estrogen breakdown products show up in urine and raised SHBG, though a lower amount in a shorter trial did not shift the ratio. 1 3 4 Those are lab markers. No randomized trial has shown that DIM improves PMS, acne, mood, weight or menopause symptoms, or lowers anyone's cancer risk. 5
- 02The milligrams on DIM labels are not comparable
Many studies used a formulated, absorption-enhanced product (BioResponse DIM) and give the weight of that product; in one trial, 300 mg of it supplied 75 mg of DIM. 4 A label that lists 300 mg of DIM itself is above the DIM content of the trials.
DIM changes how your body breaks down estrogen, and that is about all it has been shown to do. DIM, short for diindolylmethane, forms in the stomach from indole-3-carbinol, a natural chemical in broccoli, cabbage, kale and Brussels sprouts. 5 In trials it raised the ratio of two estrogen breakdown products in urine and raised SHBG, the blood protein that carries estrogen and testosterone. 1 2 Those are lab changes; no randomized trial has shown DIM eases PMS, acne, menopause symptoms or weight, and it lowered the active forms of tamoxifen, a breast cancer drug. 5 1 This guide grades each use, explains the milligram confusion on labels, and lists who should avoid it.
What is DIM?
DIM forms when indole-3-carbinol from chopped or chewed cruciferous vegetables meets stomach acid 5, and when women swallowed indole-3-carbinol, DIM was the only related compound found in their blood 8. For the basics, what it is and what it does in your body has its own page. This guide covers what the evidence shows, how much studies use, when and how to take it, DIM versus vegetables, side effects, interactions and blood tests.
DIM is sold under its own name and as BR-DIM or BioResponse DIM, an absorption-enhanced formulation used in many trials. 6 Memorial Sloan Kettering, which reviews supplements for cancer patients, sums up the state of the research plainly. 5
Both DIM and I3C may alter estrogen urinary metabolite profiles in women. However, their effects on breast cancer risk are unknown.Memorial Sloan Kettering Cancer Center, About Herbs: Diindolylmethane 5
How DIM changes estrogen
From broccoli to a different urine ratio
What DIM is good for: the evidence, graded
Strong means several good randomized trials or a meta-analysis agree; Moderate means several randomized trials, mostly positive, small or short; Limited means few or small trials or mixed results; Early means lab, animal or one pilot study only; Not supported means good trials found no benefit. See supplements explained for how we grade. Even the best-supported row below is a change in lab markers, not a health outcome.
| Use | What the research found | Evidence | Source |
|---|---|---|---|
| Shifting estrogen metabolism (urine markers) | 12-month RCT, 130 women on tamoxifen: 2/16-alpha-hydroxyestrone ratio up (+3.2 vs -0.7 on placebo). 30-day pilot, 19 postmenopausal women: 2-hydroxyestrone up, ratio up 47% (not significant). A 30-day RCT at 75 mg: no change. | Limited | 1 2 4 |
| Raising SHBG | SHBG rose by about 25 nmol/L vs 1.1 on placebo over 12 months. | Limited | 1 |
| Breast density | No change on mammogram or MRI after 12 months. | Not supported | 1 |
| Body fat | One 30-day RCT in 60 premenopausal women: body fat percentage fell slightly more than on placebo. | Early | 4 |
| PMS, period symptoms, acne, mood, "estrogen dominance" | No randomized trials found. | Early | 5 |
| Testosterone or estrogen in healthy men | No randomized trials in healthy men; small studies in men with prostate cancer only. | Early | 5 |
| Cervical cell changes (taken by mouth) | RCT, 64 women with CIN 2 or 3: improvement was common in both groups and no outcome differed between DIM and placebo. | Not supported | 10 |
| Cancer prevention | Lab studies only; no human trials of cancer outcomes. | Early | 5 |
What does DIM do for women?
The largest trial gave 130 women taking tamoxifen for breast cancer either 150 mg of BioResponse DIM twice a day or a placebo for 12 months; 98 finished. 1 DIM raised the urinary 2/16-alpha-hydroxyestrone ratio (median +3.2 vs -0.7 on placebo) and SHBG (+25 vs +1.1 nmol/L), but breast density on mammogram and MRI did not change, and blood levels of tamoxifen's active forms fell. 1 Smaller studies agree on the urine shift: a 30-day pilot of 108 mg a day in 19 postmenopausal women with a history of early breast cancer raised 2-hydroxyestrone, and a lab dataset of 909 women reporting DIM use found different levels of almost every urinary estrogen compared with 18,385 non-users. 2 3 The lab dataset was not a trial; it compared people who chose to take DIM with people who did not.
Dose seems to matter. In a 30-day randomized trial in 60 Mexican premenopausal women, 75 mg of DIM a day (given as 300 mg of a formulated product) did not raise the estrogen ratio, though body fat percentage fell a little more than on placebo (p = 0.04). 4 The authors called for studies of other doses.
What does DIM do for men?
Men often buy DIM hoping to block estrogen or raise testosterone, sometimes alongside testosterone products. No randomized trial in healthy men has tested either. 5 Small studies in men with prostate cancer, where DIM may block the androgen receptor (the testosterone docking site), are early and not a reason for anyone else to take it. 5 Low testosterone is diagnosed from symptoms and repeated morning blood tests; see low testosterone and the free testosterone calculator. DIM is not a treatment for it.
How much DIM do studies use?
These are amounts from research, as history, not a dose for any reader. No upper limit has been set for DIM by any US authority.
| Study | Amount | Form, length and people | Source |
|---|---|---|---|
| Tamoxifen RCT | 150 mg twice a day | BioResponse DIM, 12 months, 130 women | 1 |
| Postmenopausal pilot | 108 mg of DIM a day | BioResponse DIM, 30 days, 19 women | 2 |
| Premenopausal RCT | 75 mg of DIM a day (300 mg of formulated product) | DIM-BR, 30 days, 60 women; no ratio change | 4 |
| Single-dose safety study | 50 to 300 mg once | BioResponse DIM; side effects first reported at 300 mg, which gave no higher blood level than 200 mg | 6 |
| Cervical cell trial | About 2 mg per kg of body weight a day | BioResponse DIM, 12 weeks, 64 women | 10 |
The LifeFrom capsule lists 300 mg of DIM. Because many studies report the weight of a formulated product rather than DIM itself (in one trial 300 mg of product held 75 mg of DIM), 300 mg of DIM is above what the trials delivered: the pilot gave 108 mg of DIM a day and the premenopausal trial 75 mg. 4 2 Higher is not clearly better: absorption plateaued above 200 mg of the enhanced product, and side effects first appeared at 300 mg. 6
When and how to take DIM
How DIM is usually taken
DIM is hard to absorb: even with an absorption-enhanced product, only one person given a single 50 mg dose had detectable DIM in the blood. 6 Labels, including LifeFrom's, suggest taking it with a meal. It peaks in the blood about 2 hours after a dose and is near the limit of detection by 24 hours, though in a multi-week study some women still had measurable DIM 12 hours after their last dose. 8 How long does DIM take to work? Urine marker changes were measured after 30 days to 12 months. 2 1 No trial measured when, or whether, people notice a difference. Cycling has not been studied.
DIM vs indole-3-carbinol vs vegetables
DIM vs indole-3-carbinol: DIM is what ends up in the blood
DIM side effects
| Reported in trials, usually mild | Rare case reports: same-day emergency care |
|---|---|
| Adverse events no different from placebo over 12 months 1 | Leg swelling, warmth or pain, chest pain or sudden breathlessness: a blood clot in the leg and lungs was reported in a 65-year-old man taking DIM 9 |
| Nausea and headache after a single 300 mg dose (1 of 6 people); vomiting in 1 6 | Sudden weakness, face drooping or trouble speaking: an ischemic stroke was reported in a 38-year-old woman 5 |
| Nausea in 2 of 64 women over 12 weeks 10 | A widespread rash with fever (a reaction with high eosinophils, a type of white blood cell), or sudden blurred vision 5 |
Case reports cannot prove DIM caused these events, but they matter because, as the authors of the blood clot report note, DIM binds receptors in the sex hormone pathways and has unclear effects on estrogen and androgen physiology. 9 The vision case, central serous chorioretinopathy (fluid under the retina), followed excessive daily intake for 2 months and resolved 8 weeks after stopping. 5 Any of these signs needs urgent care; mention the supplement to the treating team.
Who should avoid DIM or ask first
- Pregnancy, planning pregnancy and breastfeeding: Memorial Sloan Kettering says not to take DIM because of its hormone effects, and the LifeFrom label says not to use it if pregnant or nursing. 5 There are no pregnancy studies.
- Children: the label says adults only.
- Birth control pills or hormone therapy: ask first; DIM changes estrogen processing and may affect these medicines. 5
- Tamoxifen or a history of hormone-sensitive cancer (breast, uterine, ovarian, prostate): talk to the cancer team first. 1
- A history of blood clots or stroke, or a clotting disorder: ask first, given the case reports. 9 5
- Taking regular medicines: the label says to consult a healthcare professional; DIM may speed up the clearing of drugs handled by CYP3A4. 7
- Surgery: no specific bleeding signal, but tell the surgical team about every supplement.
DIM interactions
| Medicine | What can happen | Why | What to do |
|---|---|---|---|
| Tamoxifen | In a 12-month RCT, plasma endoxifen, 4-hydroxy-tamoxifen and N-desmethyl-tamoxifen (tamoxifen's active forms) fell with DIM. 1 | DIM changes the liver enzymes that activate tamoxifen. 5 | Avoid unless the oncologist agrees. |
| Birth control pills, menopausal hormone therapy | Possible change in how the hormones are processed. 5 | DIM alters estrogen metabolism. 1 | Ask the prescriber before combining. |
| Drugs cleared by CYP3A4 (a pharmacist can say which of yours are) | Possibly lower drug levels and less effect; shown in lab cells, not people. 7 | DIM activated PXR, a switch that turns on CYP3A4. 7 | Ask a pharmacist to check each medicine. |
| Drugs moved by MDR1 (P-glycoprotein, a drug pump) | Possibly lower drug levels; lab finding. 7 | DIM increased MDR1, a pump that pushes drugs out of cells. 7 | Ask a pharmacist. |
| Hormone blood and urine tests | SHBG and estrogen metabolites change. 1 3 | A real effect of DIM on hormones. | Tell whoever reads the results that you take DIM. |
Supplements to pair with DIM or keep apart
| Supplement | Together or apart | Why |
|---|---|---|
| Boron | Ask first | Boron also shifted estrogen and testosterone in small studies; two hormone-active supplements make results hard to read. |
| Tongkat ali, tribulus | Ask first | Sold for testosterone; stacking hormone products is untested. |
| Saw palmetto | Ask first | Sold for prostate and hair concerns tied to male hormones; combinations with DIM are untested. |
| Milk thistle and other herbs taken alongside medicines | Ask a pharmacist | DIM switched on drug-clearing machinery in lab cells; a pharmacist can check the whole list of supplements and medicines together. 7 |
| Cruciferous vegetables | Together is fine | They are the natural source of DIM's parent compound. 5 |
Blood tests worth knowing about
No routine blood test tracks DIM. The marker trials use, the urinary 2/16-alpha-hydroxyestrone ratio, is a research or specialty test, and a change in it is not proof of benefit. 1 3 The blood tests below are the ones DIM can move or that help sort out the symptoms people take it for. Ask your clinician whether any fit your situation.
| Marker | Why it matters with DIM | When it is usually checked |
|---|---|---|
| SHBG | Rose by about 25 nmol/L over 12 months on DIM. 1 | With testosterone or estrogen results |
| Estradiol | The main estrogen; DIM changes how it is broken down. 1 | Hormone workups, cycle problems, menopause |
| Estrone | The estrogen whose breakdown products make up the urine ratio. 1 | Specialty hormone panels |
| Total testosterone and free testosterone | A higher SHBG can lower the free share. 1 | Men with low-testosterone symptoms; women with acne or excess hair |
| ALT | A liver enzyme; no liver injury signal is known for DIM, but it is a general liver check for anyone on several medicines. | Routine panels |
See trends beat single readings for why one hormone result is rarely enough, liver enzymes explained for ALT, and our hormones topic for related guides.
Conditions and goals DIM comes up around
DIM comes up around menopause, PMS, acne, low testosterone and breast cancer survivorship. These are diagnosed and managed by a clinician; DIM is not a treatment for any of them, and it is never a swap for a prescribed medicine. For someone treated for breast cancer, the tamoxifen finding makes the cancer team the first call. 1
DIM in the LifeFrom pouch
| In the LifeFrom pouch | |
|---|---|
| Product | DIM |
| What one serving holds | DIM (Di Indole Methane) 300 mg; Daily Value not established |
| Form | 1 capsule, vegan capsule (hypromellose); other ingredients: rice bran, silica, magnesium stearate |
| How it is packed | One serving in each of your 30 daily pouches, with up to 8 supplements per pouch |
| Price | $7.20 a month, plus the fixed $28.50 a month packing, handling and US delivery line for the whole pouch, not per supplement (prices as of November 2026, the shop shows the current price) |
| Curated packs that include it | None |
The capsule lists 300 mg of DIM, above the DIM content of the trials, whose amounts ranged from 75 to 300 mg a day of DIM or formulated DIM. 1 2 4 It is not in any curated pack. Its label says not to use it if pregnant or nursing, to consult a healthcare professional if taking any medication, and that it is for adults only. See the shop and its packs.
This guide is general education, not medical advice, and it does not diagnose. Supplements are not FDA-approved for safety or effectiveness. The clinician who knows your history, hormones and medicines is the right person to decide whether DIM fits you. See our medical disclaimer.
Citations
- Thomson CA, Chow HHS, Wertheim BC, et al. A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen. Breast Cancer Res Treat 2017;165:97-107.
- Dalessandri KM, Firestone GL, Fitch MD, et al. Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutr Cancer 2004;50:161-7.
- Newman M, Smeaton J. Exploring the impact of 3,3'-diindolylmethane on the urinary estrogen profile of premenopausal women. BMC Complement Med Ther 2024;24:401.
- Godínez-Martínez E, Santillán R, Sámano R, et al. Effectiveness of 3,3'-diindolylmethane supplements on favoring the benign estrogen metabolism pathway and decreasing body fat in premenopausal women. Nutr Cancer 2023;75:510-9.
- Memorial Sloan Kettering Cancer Center, About Herbs. Diindolylmethane (updated October 2025).
- Reed GA, Sunega JM, Sullivan DK, et al. Single-dose pharmacokinetics and tolerability of absorption-enhanced 3,3'-diindolylmethane in healthy subjects. Cancer Epidemiol Biomarkers Prev 2008;17:2619-24.
- Pondugula SR, Flannery PC, Abbott KL, et al. Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR. Toxicol Lett 2015;232:580-9.
- Reed GA, Arneson DW, Putnam WC, et al. Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3'-diindolylmethane. Cancer Epidemiol Biomarkers Prev 2006;15:2477-81.
- Bui PV, Moualla M, Upson DJ. A possible association of diindolylmethane with pulmonary embolism and deep venous thrombosis. Case Rep Med 2016;2016:7527098.
- Del Priore G, Gudipudi DK, Montemarano N, et al. Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia. Gynecol Oncol 2010;116:464-7.
Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.



